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        A specifi  c B cell subtype in the marginal zone 
of the spleen is thought to be the producer of 
autoantibodies in several models of autoimmu-
nity (  1, 2  ). These so-called marginal zone B cells 
(MZBs), essential for defense and early responses 
against blood-borne pathogens, are phenotypi-
cally characterized by high IgM and comple-
ment receptor expression (  3  ). As an example 
of MZB involvement in self-reactivity, B cells 
are rescued from deletion in the MZB popula-
tion in mice expressing a B cell receptor with 
affi   nity for DNA (  4  ). Autoreactive MZBs can 
also be activated spontaneously without T cell 
help, and the role of these B cells as producers of 
  autoantibodies and responders to self-antigens de-
rived from apoptotic cells is supported by several 
studies (  5, 6  ). A plausible explanation is that the 
natural MZB repertoire has a low level of self-
reactivity that maintains the cells in a preactiva-
ted state enabling them to rapidly respond to 
pathogens. This feature also makes them sensitive 
to defective regulation where they may contribute 
to autoimmunity by being recruited to produce 
autoantibodies. The MZBs are predominantly 
noncirculating and reside in the marginal zone in 
the spleen, an area with a low rate of blood fl  ow 
enabling effi   cient trapping of blood-borne anti-
gens. In the marginal zone, the MZBs are in close 
contact with highly phagocytic macrophages 
called marginal zone macrophages (MZMs) (  2  ). 
The MZMs are characterized by high expression 
of the class A scavenger receptors macrophage 
receptor with collagenous structure (MARCO) 
and scavenger receptor A (SR-A) (  2  ). MARCO 
and SR-A bind a variety of self- and foreign 
ligands, including modifi  ed low-density lipo-
protein and bacterial components (  2, 7  ). The ex-
pression of these receptors as well as others such as 
the C-type lectin SIGNR1 and the strategic posi  -
tion of the MZMs make them competent trappers 
of antigen from the blood and thus an important 
component in MZB activation. 
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  Apoptotic cells are considered to be a major source for autoantigens in autoimmune 
diseases such as systemic lupus erythematosus (SLE). In agreement with this, defective 
clearance of apoptotic cells has been shown to increase disease susceptibility. Still, little is 
known about how apoptotic cell  –  derived self-antigens activate autoreactive B cells and 
where this takes place. In this study, we fi  nd that apoptotic cells are taken up by specifi  c 
scavenger receptors expressed on macrophages in the splenic marginal zone and that mice 
defi  cient in these receptors have a lower threshold for autoantibody responses. Further-
more, antibodies against scavenger receptors are found before the onset of clinical symptoms 
in SLE-prone mice, and they are also found in diagnosed SLE patients. Our fi  ndings describe 
a novel mechanism where autoantibodies toward scavenger receptors can alter the response 
to apoptotic cells, affect tolerance, and thus promote disease progression. Because the 
autoantibodies can be detected before onset of disease in mice, they could have predictive 
value as early indicators of SLE. 2260 SCAVENGER RECEPTORS IN LUPUS | Wermeling et al.
  develop spontaneous SLE, there are autoantibodies produced 
recognizing both SR-A and MARCO. These antibodies can 
be detected before onset of disease, suggesting a mechanism 
where initial break of tolerance against scavenger receptors 
leads to subsequent alteration in clearance in the margi-
nal zone and fi  nally to disease. The anti-scavenger recep-
tor antibodies are also found in patients with SLE, defi  ning 
these as a new and potentially clinically relevant marker in 
human disease. 
    RESULTS AND DISCUSSION   
  Apoptotic cells are trapped by macrophages in the marginal 
zone of the spleen 
  First, we studied if apoptotic cells are localized to the margi-
nal zone of the spleen and could be a source for autoantigens 
in innate B cell activation. WT mice were injected i.v. with 
labeled apoptotic cells, and spleens were collected at diff  erent 
time points. We found that the injected apoptotic cells were 
already trapped by phagocytes in the marginal zone of the 
spleen 30 min after injection (  Fig. 1 A  ).   At 5 h, fewer cells 
were found, indicating swift clearance in this region (not 
depicted). Several subtypes of potent APCs reside in the 
  A source of autoantigens for B cell activation in systemic 
lupus erythematosus (SLE) is apoptotic cells, and defects in 
apoptotic cell clearance increase susceptibility to SLE (  8, 9  ). 
This clearance defect can be detected in the skin, spleen, and 
circulation, suggesting that putative autoantigen is available at 
multiple sites. Because activation/selection of autoreactive 
MZBs needs to include access to autoantigens, we investigated 
whether apoptotic cells are localized to the marginal zone of 
the spleen and thereby could be a source for autoantigens in 
innate B cell activation. We fi  nd that i.v. injected apoptotic 
cells are rapidly trapped by MZMs in the marginal zone of 
the spleen. 
  SR-A has been shown to bind apoptotic cells, and we 
show here that MARCO too has this ability, indicating that 
these two receptors take part in clearance of apoptotic cells 
in the marginal zone. When deleting MARCO, SR-A, or 
both receptors, mice have a lower tolerance threshold and 
develop higher anti-DNA antibody titres spontaneously and 
after injection of apoptotic cells. This shows that proper 
clearance by these receptors in the marginal zone is needed 
for correct regulation of B cell tolerance. In addition, we 
fi  nd that in Fc    RIIB      /      and (NZB x NZW)F1 mice, which 
  Figure 1.     Apoptotic cells bind MARCO and SR-A, and apoptotic cells are trapped in the marginal zone of the spleen. (A) PKH26-labeled (red) 
apoptotic cells were injected i.v. in BALB/c mice, and spleens collected after 30 min were stained with anti-CD11c (DCs; green) and anti-B220 (B cells; 
pseudo-colored blue). Bar, 100     m. (B; top) A serial cryostat section stained with anti-MARCO (MZMs; green). Bar, 100     m. (Bottom) Higher magnifi  cation 
of MZM-binding apoptotic cells (red) stained with both anti-MARCO and anti  –  SR-A (green). Arrows indicate apoptotic cells taken up by MZMs. Bar, 10    m. 
(C) In vitro binding assay using CHO cells transfected with mouse MARCO or SR-A and incubated with labeled apoptotic cells (red). (Left) Cells stained 
with anti-MARCO or anti  –  SR-A (green) and DAPI nuclear staining (blue). Bar, 10     m. (Right) Quantifi  cation of apoptotic cell binding showing the amount 
of apoptotic cells binding transfected or nontransfected cells on the same slide. 10  –  15% of the total amount of CHO cells was successfully transfected. 
In A and B the Leica confocal system was used, and in C the Leica DMRB microscope was used (refer to Materials and methods).     JEM VOL. 204, October 1, 2007  2261
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WT, which is suggestive of a higher degree of pathogenicity 
(  Fig. 2 C  ) (  18  ). In agreement with the anti-DNA ELISA 
data, antinuclear autoantibody (ANA) titres were also higher 
in injected DKO mice (  Fig. 2 D  ). 
  A conceivable explanation for the increased anti-DNA 
response is that deletion of the receptors leads to a decreased 
clearance of apoptotic cells, in turn resulting in increased self-
antigen load. With this in mind, we investigated whether the 
mice displayed any defects in the clearance of apoptotic cells. 
The number of circulating apoptotic cells in the blood did not 
diff  er between DKO mice and WT mice, and furthermore 
marginal zone, including DCs, known to be able to ingest 
apoptotic cells (  10, 11  ). However, even though some apop-
totic cells were taken up by CD11c     DCs, we found that at 
early time points, 30 min and 5 h, the apoptotic material pri-
marily bound to MZMs. The cells trapping the apoptotic cells 
were MZMs, defi  ned in serial sections by their expression of 
specifi  c scavenger receptors MARCO and SR-A (  Fig. 1 B  ) 
(  2, 12  ). SR-A has been shown to bind apoptotic cells (  13  ), 
and when we investigated whether MARCO has this same 
ability, we found that both receptors could bind apoptotic cells 
in transfection experiments. In this assay, clustering of apop-
totic cells could be seen on MARCO- or SR-A  –  transfected 
cells and not on nontransfected cells on the same slide (stained 
with DAPI) (  Fig. 1 C  ). These results show that MZMs have 
the ability to trap apoptotic cells in the marginal zone and 
that both MARCO and SR-A receptors can contribute to 
the clearance in this region. 
  Higher autoantibody responses in scavenger receptor  –
  defi  cient mice 
  The fi  nding that MZMs are involved in clearance of apop-
totic cells in the marginal zone raised the possibility that they 
could regulate the response and availability of self-antigens in 
the marginal zone for recognition by MZBs and DCs. In an 
analogous system, proper clearance of apoptotic cells by tan-
gible body macrophages has been shown to be important in 
the germinal center microenvironment where B cells are ac-
tivated and/or selected (  14  ). Hanayama et al. show that the 
inability of macrophages to ingest apoptotic cells due to lack 
of MFG-E8 production in the germinal center leads to auto-
immunity. To explore whether MARCO     and SR-A     macro-
phages are involved in regulating autoimmune responses, 
we investigated the ability to maintain tolerance after injec-
tion of syngeneic apoptotic cells, without adjuvant, in mice 
defi  cient in one or both of these receptors (  15, 16  ). Apop-
totic cells were injected weekly four times in WT, SR-A      /     , 
MARCO      /     , and double KO (DKO) mice in a protocol 
adopted from Mevorach et al. (  17  ), and anti-DNA responses 
were measured with ELISA. All receptor-defi  cient mice had 
an elevated and more rapid response to apoptotic cells com-
pared with control mice, and the phenotypes were additive, 
resulting in the highest response in the DKO mice (  Fig. 2 A  ).   
Notably, the DKO mice, but not single KO mice, displayed 
signifi  cantly (P = 0.01) higher levels of IgM and IgG anti-
DNA without provocation by apoptotic cells, suggesting 
spontaneous development of anti-DNA autoimmune responses 
(  Fig. 2 A   and not depicted). However, at the time points 
tested, we could fi  nd no spontaneous development of kidney 
pathology as measured by proteinurea and histological exam-
ination (not depicted). No major diff  erences could be seen 
with regard to Ig isotype of anti-DNA antibodies in the dif-
ferent KO mice, except that MARCO defi  ciency tended to 
contribute more to IgM anti-DNA titres and SR-A defi  -
ciency to IgG anti-DNA titres (  Fig. 2 B  ). The specifi  c IgG 
response was mainly of the IgG  2b   subclass in all mice, and the 
DKO mice tended to have a higher IgG  2a/b  /IgG  1   ratio than 
  Figure 2.     Class A scavenger receptors regulate tolerance against 
i.v.   injected apoptotic cells.   (A) 10  7   syngeneic apoptotic cells were 
injected i.v. four times weekly in WT and MARCO     /   /SR-A    /     DKO  mice 
(C57BL/6 background). IgM and IgG anti-DNA responses in serum were 
measured pre-immune (PI) at days 12 and 19. Data are shown as mean     
SEM (  n    8 per genotype). (B) The anti-DNA response in WT, MARCO     /   , 
SR-A     /    , and DKO mice at days 12 (IgM) and 19 (IgG). Individual data and 
mean are presented (  n    8 per genotype). As a control in these experi-
ments, a quantitative analysis of serial dilution of pooled MRL  lpr   sera  that 
develop spontaneous disease revealed that the levels of IgM and IgG anti-
DNA antibodies are     5  –  40 times that of WT mice injected with apoptotic 
cells. The PI values for MARCO     /     and  SR-A    /     were not statistically 
different from WT controls (not depicted). (C) Subclass analysis of the 
anti-DNA response at day 26, after the fourth injection of apoptotic cells. 
Data are shown as mean      SEM of the OD 405-nm ratio between IgG  2a /
IgG  2b   and  IgG 1   ( n    8 per genotype). (D) Representative ANA pattern from 
DKO and WT mice after the fourth injection (d26). Bar, 50     m. *, P      0.05; 
**, P      0.01; ***, P      0.001 (nonparametric Mann-Whitney U-test).     2262 SCAVENGER RECEPTORS IN LUPUS | Wermeling et al.
  Class A scavenger receptors are autoantigens in mouse 
and man 
  The ability to bind apoptotic cells and participate in clear-
ance is a characteristic that SR-A and MARCO have in 
common with the structurally related complement protein 
C1q (  21  ). In SLE, autoantibodies toward C1q can be found, 
and data suggest that they increase the severity of glomer-
ulonephritis, but there is also the possibility that they may 
aff  ect clearance of apoptotic cells (  22  ). With these disease 
processes in mind, the question was raised if scavenger re-
ceptors in a similar manner could function as autoantigens 
and blocking antibodies could interfere with their clearance 
function. To investigate possible development of autoanti-
bodies binding class A scavenger receptors, sera from lupus-
prone (NZB x NZW)F1 and Fc    RIIB      /      mice were tested 
for IgG anti-MARCO activity by ELISA (  23, 24  ). In these 
experiments, sera from 2-, 4-, 6-, and up to 14-mo-old mice 
were tested, spanning the development of disease that starts 
at 5 mo of age in (NZB x NZW)F1 mice and at 3 mo of age 
in Fc    RIIB      /      mice, as determined by end-organ infl  amma-
tion resulting in pathology such as proteinurea and increased 
BUN levels. There is also an accumulation of autoantibodies 
such as IgG anti-DNA levels (  Fig. 3, A and C  ) and anti-C1q 
(Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20070600/DC1).   Interestingly, signifi  cant levels of IgG 
anti-MARCO antibodies could be detected as early as 2 mo 
and peaked at 6  –  9 mo (  Fig. 3, B and D  ). The binding of 
the autoimmune sera to MARCO could be blocked by add-
ing an antibody toward the ligand-binding domain (  Fig. 3 E  ) 
there were no detectable diff  erences in the clearance of i.v. 
injected apoptotic cells (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20070600/DC1). The lack of 
diff  erence in systemic clearance suggests a mechanism where 
specifi  c local change in the response in the marginal zone is 
responsible for the change in anti-DNA levels. In line with 
this, the scavenger receptor  –  defi  cient mice have a normal 
MZB population, reduced MZM population, and a higher 
response to thymus-independent type 2 (TI-2) antigens (un-
published data and reference   16  ). The fact that deletion of 
type A scavenger receptors renders mice more susceptible to 
autoimmunity makes them possible candidates for suscepti-
bility genes in SLE. In mice, the MARCO gene is located on 
chromosome 1 (122 Mb from the centromere), nearby but 
slightly proximal to the major lupus susceptibility loci of the 
NZB, NZW, and BXSB mice (  19  ). Nevertheless, one of the 
BXSB loci,   Bxs2  , linked to ANA and anti-DNA production, 
peaks at the   D1Mit12   marker (122 Mb) in the vicinity of 
  Marco   (  20  ), suggesting that   Marco   may contribute to SLE sus-
ceptibility. The SR-A gene, on chromosome 8 in mice, has 
not been shown to reside within the known susceptibility 
loci for SLE or other autoimmune diseases. 
  Figure 3.     Anti-MARCO antibodies are found in SLE-prone mice. 
(A and C) IgG anti-DNA levels in 2  –  8-mo-old (NZB x NZW)F1 mice and in 
3 – 14-mo-old  Fc  RIIB    /     mice. Control mice are 3-mo-old C57BL/6 mice. 
(B and D) IgG anti-MARCO reactivity in 2  –  8-mo-old (NZB x NZW)F1 mice, 
3 – 14-mo-old  Fc  RIIB    /     mice, and 3-mo-old C57BL/6 mice. (E) Binding 
to MARCO in the anti-MARCO ELISA blocked with a rat monoclonal antibody 
(ED31) against MARCO, but not with an isotype control (  n    2). (F) CHO 
cells transfected with mouse MARCO or SR-A stained with sera from 
(NZB x NZW)F1 mice and anti  –  mouse IgG-FITC. Arrows indicate transfected 
cells stained by the mouse sera. Bar, 20    m.   
  Figure 4.     Anti-MARCO antibodies affect TI-2 B cell responses in 
C57BL/6 mice. WT mice were injected with 5     g of the TI-2 antigen 
TNP-Ficoll alone (  n    7) or with 100     g rat IgG anti-MARCO (  n    7) or 
a rat isotype control (  n    4). The data are shown for IgG (A), IgM (B), and 
IgG3 (C) anti-TNP response pre-immune (PI) at days 5 and 14. In A, data 
are presented as mean      SEM, and in B and C, individual data and mean 
are shown. *, P      0.05 (nonparametric Mann-Whitney U-test. TI-2 plus 
anti-MARCO compared with TI-2 or TI-2 plus control group).     JEM VOL. 204, October 1, 2007  2263
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mice leads to increased responses to self-antigens. Furthermore, 
both mice developing spontaneous autoimmune disease and pa-
tients with SLE display autoantibodies toward these receptors. In 
mice, these autoantibodies are found before the onset of dis-
ease, and thus anti-scavenger receptor antibodies have poten-
tial as predictive markers for disease. We propose that these 
autoantibodies lower tolerance to nuclear antigens, opening up 
for subsequent B cell activation by apoptotic cells, giving 
antibody responses such as anti-DNA that ultimately lead to 
disease (  Fig. 5 D  ). 
  MATERIALS AND METHODS 
  Mice.     Mice were age and sex matched and kept and bred under pathogen-
free conditions according to local ethical guidelines. SR-A      /     , MARCO      /     , 
and DKO mice (  15, 16  ) were backcrossed to the C57BL/6 strain for   	  10 
generations. (NZB x NZW)F1 mice were from The Jackson Laboratory, 
and Fc    RIIB      /      mice were generated at The Rockefeller University (  24  ). 
In all studies except noted, WT mice were of the C57BL/6 strain. (NZB x 
NZW)F1 mice were housed at University of Geneva, and Fc    RIIB      /      mice 
were housed at The Rockefeller University. All other mice were maintained 
and was not aff  ected by treatment with DNase I (Fig. S3). 
The presence of anti-MARCO autoantibodies in (NZB x 
NZW)F1 mice was further confi  rmed by staining transfected 
cells expressing either the MARCO or SR-A protein (  Fig. 
3 F  ), implicating class A scavenger receptors as autoantigens 
in SLE. The presence of antibodies toward MARCO and 
SR-A before the onset of disease in (NZB x NZW)F1 and 
Fc    RIIB      /      mice is compatible with a mechanism where 
reactivity toward these receptors results in a decreased local 
clearance of apoptotic cells in the spleen. In addition, i.v. in-
jection of anti-MARCO antibodies has been shown to lead 
to migration of MZBs, suggesting that these autoantibodies 
could have dual eff  ects, both activating MZBs and block-
ing clearance, giving increased access to self-antigens (  25  ). 
To address whether anti-MARCO antibodies are involved 
in direct regulation of MZB activation and innate immune 
responses, we injected them together with the TI-2 antigen 
TNP-fi  coll, which has been shown to be MZB dependent 
(  26  ). We found that anti-MARCO antibodies, but not the 
isotype control, enhanced the response (  Fig. 4 A  ), and espe-
cially the early MZB-related subclasses IgM and IgG3 (  Fig. 4, 
B and C  ).   This suggests that anti-MARCO reactivity has a 
direct and T cell  –  independent eff  ect on the activation thresh-
old and response of MZB cells. 
  Class A scavenger receptors are highly conserved among 
species, and MARCO has a 74% amino acid identity be-
tween mice and man (  7  ). This led us to investigate whether 
patients newly diagnosed with SLE also displayed antibodies 
toward these receptors. When we tested 20 SLE patients 
and 19 healthy controls, the patients showed signifi  cantly 
(P = 0.0035) higher reactivity toward the MARCO protein 
(  Fig. 5 A  ).   The patient group was selected to refl  ect an early 
onset of the disease and had low but signifi  cant levels of 
anti-DNA antibodies (  Fig. 5 B  ). Even so, the anti-DNA 
levels did not correlate with the anti-MARCO levels, sug-
gesting a diff  erence in the regulation that may refl  ect the 
situation in the mice (  Fig. 5 C  ). It remains to be determined 
whether anti-scavenger receptor antibodies also appear be-
fore the onset of clinical disease in humans, as the mouse 
data indicate. The fact that the MZB compartment contains 
memory B cells both in mouse and man (  27  ) suggests that 
anti-scavenger receptor antibodies may be involved in the 
characteristic fl  ares of SLE disease activity. Another possible 
connection to SLE-related complications is that MARCO 
and SR-A are receptors for oxidized low-density lipoprotein. 
This connection could possibly explain why up to 54% of 
patients with SLE develop cardiovascular disease (  28  ). The 
association with cardiovascular disease has been suggested to 
be correlated with impaired clearance of apoptotic cells, but 
not with any typical measures of SLE activity (  28  ). Our data 
show that anti-scavenger receptor antibodies are an attrac-
tive candidate for such a marker. 
  In conclusion, herein we describe a novel mechanism for 
autoimmunity where MZMs regulate the early access and re-
sponse to apoptotic cells in the spleen through class A scav-
enger receptors. As a consequence, lack of these receptors in 
  Figure 5.     SLE patients have circulating anti-MARCO antibodies. 
(A) IgG anti-MARCO reactivity is found in sera from SLE patients. 
sMARCO or blocking buffer  –  coated ELISA plates were incubated with 
sera from SLE patients (  n    20) and healthy individuals (  n    19). Data 
are shown as anti-MARCO data minus anti-block buffer data to reduce 
the level of binding to the block buffer. (B) IgG anti-DNA activity in SLE 
patients and healthy individuals was measured by ELISA. The patient 
indicated by an arrow had an OD  405   value of 1.44. (C) Correlation between 
anti-MARCO and anti-DNA levels in the patient group. The two measures 
do not correlate as deduced by linear regression analysis (R  2    0.038). 
(D) A model describing the proposed mechanism where anti-scavenger 
receptor antibodies infl  uence SLE development by altering the marginal 
zone response to apoptotic cells. (1.) Anti-scavenger receptor autoanti-
bodies alter the uptake of apoptotic cells by MZMs in the marginal zone 
leading to an increased local self-antigen load. (2.) Subsequently, auto-
reactive B cells have increased access to self-antigens in this area. 
(3.) In addition, engagement of the MARCO receptor by specifi  c antibodies 
has the ability to send an activating signal to MZBs, suggesting a dual 
effect by the anti-scavenger receptor autoantibodies resulting in 
disease promotion.   2264 SCAVENGER RECEPTORS IN LUPUS | Wermeling et al.
coated with 1  –  2     g/ml sMARCO in PBS overnight at 4  °  C. Plates were 
washed fi  ve times with PBS plus 0.05% Tween 20 and blocked with an ex-
cess of blocking buff  er for 2 h at room temperature (RT). Blocking buff  er 
was tapped off   and serum samples were added diluted in blocking buff  er 
followed by a 2-h incubation in RT. The plates were then washed as 
above, and the following secondary antibodies were added: anti  –  human 
IgG  –  horseradish peroxidase (DAKO) or anti  –  mouse IgG-AP (Southern-
Biotech). After a 1-h incubation at RT, plates were washed and substrate 
was added. All samples were run in duplicates and corrected for back-
ground binding. 
  Patients.     20 SLE patients classifi  ed by the American College of Rheumatol-
ogy criteria (  32  ) and 19 matched healthy individuals were selected. Sera from 
young SLE patients (median age 35) with low anti-DNA titres were chosen 
because mouse data indicate that anti-MARCO reactivity can be found early 
in development of the disease. The use of patient samples was approved by 
the local ethical committee (the North Stockholm district court). 
  Statistical analysis.     Nonparametric Mann-Whitney U test was performed 
using Statistica software (StatSoft Inc.) and GraphPad Prism 4 (GraphPad 
Software, Inc.). P      0.05 was considered signifi  cant. 
  Online supplemental material.     Fig. S1 shows basal level of apoptotic cells 
and clearance of apoptotic cells from the blood in scavenger receptor DKO 
mice and controls. Fig. S2 shows a time course of spontaneous anti-C1q lev-
els in (NZBxNZW)F1 and Fc    RIIB      /      mice. Fig. S3 demonstrates that 
binding of (NZBxNZW)F1 sera to MARCO is not due to DNA contami-
nation. The online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20070600/DC1. 
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